MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a leading cause of dementia, pathologically characterized by progressive synaptic degeneration, brain atrophy, extracellular amyloid-beta (Aβ) plaque deposition, and neurofibrillary tangles composed of hyperphosphorylated tau.